NCT06673914Active, not recruiting
EFFECTS OF OLEUROPEIN ON BLOOD PARAMETERS AND INFLAMMATORY MARKERS IN ADULTS WITH METABOLIC SYNDROME
Source: ClinicalTrials.gov · Last updated 5 Nov 2024
Brief summary (registry, in English)
The aim of this study is to determine the effect of 6 weeks supplementation of oleuropein on individuals diagnosed with metabolic syndrome. The baseline and end biochemical parameters and anthropometric measurements will be compared with control subjects.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 34 (actual)
- First submitted
- 23 Jul 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Atlas University
- Diseases
- Obesity
- NCT number
- NCT06673914
What you commit to
- Study type: Interventional
- Participants enrolled: 34
- From 1 Nov 2024 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Starting to use any medication or nutritional supplement during the study
Other illness
- Occurrence of the problem and/or infection
- Failure to comply with the regulated medical nutrition treatment
- Failure to participate in routine meetings and failure to complete necessary measurements
Other
- The patient included in the study leaves the study
- Any health issues that may affect the results of the research during the research.
- Becoming pregnant during the research
- Being in the experimental group and not consuming extract regularly
- Leaving study voluntarily
Who the study is looking for
- Individuals who volunteer to participate in the study by signing the voluntary consent form
- Diagnosed with Metabolic Syndrome
- Individuals who did not have any infection at the time the study started
- Not consuming any medication
- Not pregnant or lactating
- Women aged 18-49 who have not entered menopause and men in the same age group
- Willing to consume the given extract
- Not allergic or intolerant to olive leaves
- No history of drug use
- People with a BMI below 40 kg/m2
Age in the registry: 18 years to 49 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atlas University Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.